European Commission vs Big Pharma, or profit vs access?
Drug Discovery World
MARCH 29, 2023
What of the increased possibilities for ‘replacement pharmacy compounding’ for weekly hospital supplies, and for routine manufacturing of cell and gene therapies without a marketing authorisation? At the same time, we have to find and implement actions that improve the significant variance in accessing new medicines across Europe.
Let's personalize your content